MGD024

About MacroGenics

MacroGenics is a fully-integrated biopharmaceutical company with a mission to develop and commercialize life-changing, antibody-based cancer medicines. Its strategy is built upon a suite of proprietary technology platforms that generate a diverse pipeline of novel bispecific antibodies and ADCs, both for proprietary development and strategic partnerships. The company has advanced multiple candidates into clinical trials, retains economic rights to several partnered/commercialized assets, and maintains in-house GMP manufacturing capabilities to control its development destiny.

Therapeutic Areas